Finnish Medicines Agency (FIMEA)
Dr. Niklas Ekman has a background in molecular cell and cancer biology. After joining the Finnish Medicines Agency (FIMEA) in late 2006, he worked the next eleven years as a quality assessor for biological medicinal products. His main activities and responsibilities included assessments of European Medicines Agency (EMA) centralized marketing authorization applications, scientific advices, as well as national clinical trial applications. Currently, Dr. Ekman is the head of the biological section at the Finnish Medicines Agency. At EMA, Dr. Ekman is the vice-chair of the Biosimilar Medicinal Products Working Party (BMWP) and the Finnish alternate member of the Biologics Working Party (BWP).